A Washington University study reveals that nasal COVID-19 vaccines could prevent virus transmission, a significant advantage over traditional injectable vaccines. This finding could be crucial in addressing future respiratory pandemics.
Research on hamsters suggests that vaccines aimed at the nose and mouth could be crucial in curbing the transmission of respiratory infections.
The rapid development of DOI: 10.1126/sciadv.adp1290
The study was funded by the National Institute of Allergy and Infectious Diseases.
Disclosures: M.S.D. is a consultant for inbios, vir Biotechnology, Ocugen, topspin therapeutics, GlaxoSmithKline, Allen & Overy llP, Moderna and immunome. the Diamond laboratory has received unrelated funding support in sponsored research agreements from vir Biotechnology, emergent BioSolutions and Moderna. M.S.D. and A.O.h. are inventors of the chAd-SARS-cov-2 technology, which Washington University has licensed to Bharat Biotech and Ocugen inc. for commercial development. the Boon laboratory has received unrelated funding support in sponsored research agreements from Greenlight Biosciences inc. the Boon laboratory has received funding support from Abbvie inc. for the commercial development of SARS-cov-2 mAb and Moderna for unrelated work. All other authors declare that they have no competing interests.
/https://tf-cmsv2-smithsonianmag-media.s3.amazonaws.com/filer_public/d1/82/d18228f6-d319-4525-bb18-78b829f0791f/mammalevolution_web.jpg "How to Make a Mammal in Nine Evolutionary Steps")
Discussion about this post